ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2427

Exosomes Derived from T Lymphocytes Enhance Expression of CXCL10 Induced By IFN-γin Rheumatoid Arthritis Synovial Fibroblasts Via Pattern Recognition Receptor, RIG-I

Kunihiko Umekita, Shunichi Miyauchi, Koshou Iwao, Mao Rikitake, Yuuki Rikitake, Chihiro Kawada, Ayako Aizawa, Yumi Kariya, Motohiro Matsuda, Takeshi Kawaguchi, Hajime Nomura, Ichiro Takajo and Akihiko Okayama, Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Inflammation, innate immunity and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Exosomes have been recognized to have a function in cell-to-cell communication by transporting various factors including proteins and nucleic acids. These factors impact cell viability and cell differentiation, and are likely to play a prominent role in the pathophysiology of rheumatoid arthritis (RA); however, it is still not reveal that the roles of exosomes as inflammatory mediator in pathogenesis of RA. The purpose of this study is to investigate the role of T lymphocytes derived exosomes in the pathogenesis of RA.

Methods: Exosomes were isolated and purified from cultured medium of T lymphocytes cell line (JK). RA synovial fibroblasts (RASFs) were cultured with exosomes derived from JK with or without IFN-gamma for 24hours. Total RNA was extracted using TRIZOL methods. The expression of RIG-I, TLR3, IL-6 and CXCL10 mRNA in RASFs was measured using real-time quantitative PCR. The protein levels of RIG-I and TLR3 were determined by immune blotting. Silencing of RIG-I and TLR3 in RASF was performed by transfection of siRNA against these proteins.

Results: Treatment with PMA/Ionomycin increased the release of exosomes from JK. Large amount of RNA was detectable in exosomes derived from JK. Exosomes derived from JK increased the expression of IL-6 and CXCL10 mRNA in RASFs. When IFN-gamma is added to the culture medium of RASFs, increased expression of both RIG-I and TLR3 protein in RASF was observed in a dose dependent manner. IFN-gamma also induced the expression of CXCL10 mRNA, but not IL-6 mRNA, in RASF. Exosomes derived from JK significantly enhances the expression of CXCL10 mRNA, but not IL-6 mRNA, in RASF treated with IFN-gamma. Finally, silencing of RIG-I, but not TLR3, suppressed the expression of CXCL10 in RASF induced by co-stimulation of both exosomes and IFN-gamma.

Conclusion: The present study demonstrates that exosomes derived from JK enhance IFN-gamma induced expression of CXCL10 in RASF via pattern recognition receptor, RIG-I. The interaction between exosomes derived from T-cells and RIG-I can be a therapeutic target for RA.


Disclosure: K. Umekita, None; S. Miyauchi, None; K. Iwao, None; M. Rikitake, None; Y. Rikitake, None; C. Kawada, None; A. Aizawa, None; Y. Kariya, None; M. Matsuda, None; T. Kawaguchi, None; H. Nomura, None; I. Takajo, None; A. Okayama, None.

To cite this abstract in AMA style:

Umekita K, Miyauchi S, Iwao K, Rikitake M, Rikitake Y, Kawada C, Aizawa A, Kariya Y, Matsuda M, Kawaguchi T, Nomura H, Takajo I, Okayama A. Exosomes Derived from T Lymphocytes Enhance Expression of CXCL10 Induced By IFN-γin Rheumatoid Arthritis Synovial Fibroblasts Via Pattern Recognition Receptor, RIG-I [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/exosomes-derived-from-t-lymphocytes-enhance-expression-of-cxcl10-induced-by-ifn-%ce%b3in-rheumatoid-arthritis-synovial-fibroblasts-via-pattern-recognition-receptor-rig-i/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exosomes-derived-from-t-lymphocytes-enhance-expression-of-cxcl10-induced-by-ifn-%ce%b3in-rheumatoid-arthritis-synovial-fibroblasts-via-pattern-recognition-receptor-rig-i/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology